Posted in | News | Business | Iron and Steel | Mining

India Globalization Capital Set to Open First of Three Iron Beneficiation Plants in Inner Mongolia

India Globalization Capital, Inc. ("IGC" or "the Company") announced the achievement of an important milestone in the execution of its strategic plan. It has scheduled to open the first of three beneficiation plants in Inner Mongolia on April 10, 2013 to drive growth in its iron ore business.

IGC has assembled an experienced team to manage both onsite operations and reporting systems. The plant is equipped with two stages of beneficiation. The first uses dry magnetic separation and the second uses a wet process. These are designed to produce ore with about 66% iron content from low-grade ore. The Company has set an initial production target of 200 tons per day with an approximate selling price of $115 per ton. IGC's initial goal would be to increase incremental production to approximately 500 tons per day as operations ramp-up to three plants.

Ram Mukunda, CEO of India Globalization Capital, said, "Just over a year ago, we articulated a strategy of growth that includes shipping low-grade ore from India to the refining facilities, and through a beneficiation process efficiently convert this ore to high-grade product. This will allow us to increase the out put of our plants and supply larger amounts of refined ore to our customers."

As previously reported, IGC has four properties in Inner Mongolia with over $500 million of estimated reserves. Inner Mongolia, with its extensive coal and iron ore deposits, has become an important steel production center. The Company contracts with regional steel mills that require high-grade iron to fulfill growing demand.

Mr. Mukunda continued, "Our short term strategy remains three pronged: 1) supply high grade iron ore from our beneficiation plants, 2) expand the supply chain for raw materials by shipping low grade ore from India to China, and 3) actively consolidate additional mines in the Inner Mongolia region that can be accretive to the Company."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.